NASDAQ · GRCE
Grace Therapeutics, Inc.
Healthcare · Biotechnology
$1.81
Down-$0.03 (-1.63%)
Updated Nov 5, 2026, 2:18 AM
SID Score
3.7/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 47.49M
- P/E ratio
- -6.84
- Dividend yield
- 0.00%
- 52-week range
- $1.67 – $5.18
- Volume
- 64.64K
- Avg. volume
- 65.65K
Price performance · GRCE
GRCE price history
1M range · 0 trading sessions · Daily adjusted prices
GRCE does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest GRCE news
The latest Smart Investors Daily articles mentioning GRCE.
Stock researchMarket Activity · Options
Company
Market Activity
Research & News

